Framingham risk assessment doesn’t accurately predict coronary artery disease, study suggests

	Tweet

If patients with suspected coronary artery disease (CAD) are excluded from further screening because of a low Framingham score, many patients with substantial Atherosclerosis (a build-up of plaque inside the arteries) will be missed, according to a study published in the May issue of the American Journal of Roentgenology (http://www.ajronline.org).

The Framingham risk assessment tool is used to estimate a person’s chances of having a heart attack based upon age, sex, total cholesterol, HDL cholesterol, smoking status, and blood pressure. “It is often recommended as the starting point for coronary disease screening; however, if a patient’s Framingham score is low enough, some doctors may eliminate them from having any further screening,” said Kevin M. Johnson, MD, lead author of the study.

The study, performed at the Yale University School of Medicine in New Haven, CT, compared the sensitivity (percentage of patients with Atherosclerosis who were correctly identified) of the Framingham score to the simple observation of whether any coronary calcium was present using coronary computed tomography (CT). It included 1,416 men and 707 women with suspected CAD and the majority of patients were asymptomatic

"Simple observation of the presence of coronary calcium was 98 percent sensitive in men and 97 percent sensitive in women for the detection of Atherosclerosis. In comparison, the Framingham risk score was only 74 percent sensitive in men and 36 percent sensitive in women for the detection of Atherosclerosis — a substantial difference,” said Johnson.

“As our study suggests, the presence of coronary artery calcium detects more patients with coronary Atherosclerosis than does the Framingham risk assessment score,” he said.

“If the Framingham risk score is used as the “gatekeeper” in a screening program for coronary Atherosclerosis and the low-risk patients are dismissed from further study, about two thirds of women and a quarter of men with substantial Atherosclerosis will be missed,” said Johnson.

###

This study appears in the May issue of the American Journal of Roentgenology. For a copy of the full study or to request an interview with Dr. Johnson, please contact Heather Curry via email at or at 703-390-9822.

About ARRS

The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the United States. Its monthly journal, the American Journal of Roentgenology, began publication in 1906. Radiologists from all over the world attend the ARRS annual meeting to participate in instructional courses, scientific paper presentations and scientific and commercial exhibits related to the field of radiology. The Society is named after the first Nobel Laureate in Physics, Wilhelm Röentgen, who discovered the x-ray in 1895. 

RELATED STORIES:
Scientists turn skin cells into beating heart muscle   Too many people get angioplasties, study suggests   New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA   Heart Damage After Chemo Linked to Stress in Cardiac Cells   What’s good or bad for the heart, may be the same for the brain   Warfarin in Heart Failure   Increased Sudden Cardiac Death Rate Among HIV Patients   Air pollution level changes in Beijing linked with biomarkers of cardiovascular disease   Lack of basic evidence hampering prevention of sudden heart attacks in sport   Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study   Heart attack patients taken to PCI hospitals first treated faster   Cameron Health’s under-skin ICD safe, effective

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]